Wearable Health Sensors and Diagnosis

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Wearable Health Sensors and Diagnosis

Sector: Diagnostics
YouTube video thumbnail

Wearable health sensors are becoming more capable as smartwatches and other devices continue to evolve. In this Bio Break episode, Nick and Nigel explore how a surprisingly small set of sensors could be used to identify a wide range of common health conditions. The conversation starts casually with a comparison between a simple Timex watch and modern smartwatches, but it quickly moves into deeper questions about sensing, diagnosis, and where wearables fit between wellness and medical devices.

How Wearable Health Sensors Are Expanding

As wearables become more advanced, they can sense more signals from the body. Nigel shares a long-standing interest in whether a limited number of sensors could diagnose many conditions. Rather than adding endless hardware, the idea focuses on selecting sensors that overlap across multiple use cases. This approach keeps systems simpler while still delivering meaningful insights.

Importantly, the discussion highlights the tension companies like Apple have faced when deciding whether a product is a wellness device or a regulated medical device. That distinction shapes how wearable health sensors are designed, validated, and positioned in the market.

Diagnosing Common Conditions with Fewer Sensors

Using a paper-based analysis, Nigel estimates that around 46 common conditions could be identified using just five sensors. These conditions tend to be ones with external or observable symptoms and may be chronic or episodic. Examples mentioned in the episode include pregnancy, common colds, asthma, and breathing difficulties.

Rather than chasing rare diagnoses, this model prioritizes conditions people experience frequently. As a result, wearable sensors can deliver more value without unnecessary complexity.

Finding the Core Sensor Set

Not every condition makes sense to include. Adding a sensor to capture only one or two extra diagnoses quickly becomes inefficient. Instead, the conversation points to a core group of sensors that form a nucleus. This nucleus provides the greatest overlap across many conditions, which is key for scalable wearable health sensors.

Reliability Still Matters

Despite all the potential of smart devices, the episode closes with a reminder that reliability is still valued. A simple watch may not diagnose conditions, but it works consistently. That contrast underscores the challenge for wearable diagnostics as they move closer to medical use.

Nick and Nigel demonstrating how aminoglycoside antibiotics work using Lego bricks in a Bio Break episode

Nick Allan and Nigel Syrotuck explain exactly how aminoglycoside antibiotics work and why they’re so effective at killing bacteria.

Engineer reviewing a colorful mind map diagram across dual monitors and laptop while collaborating with a remote team on a video call during an online whiteboard risk analysis session

Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.

Product designer sketching early-phase concept wireframes on glass whiteboard during ideation session

Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.

Engineer in cleanroom assembling precision medical device prototype with optical components

Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.